Solesence, Inc. (SLSN) stock
SLSNNasdaqPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/301% above fair value
$1.69+0.09 (+5.62%)
Close on Nov 17, 2026Market cap $119.39MP/E –Yield –
Solesence r&d expenses
Research and development expenses are spending on new products and technology.
Solesence's R&D Expenses for the twelve months ending Jun 30, 2026 was $4.11M, up 1.8% year over year. For fiscal 2025 it was $4.09M, up 6.6% from the year before. Over ten years it grew 12.4% a year on average. The highest annual figure on record is $4.09M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.09M | +6.6% |
| FY2024 | Dec 31, 2024 | $3.84M | 0.0% |
| FY2023 | Dec 31, 2023 | $3.84M | +26.3% |
| FY2022 | Dec 31, 2022 | $3.04M | +35.9% |
| FY2021 | Dec 31, 2021 | $2.24M | +42.3% |
| FY2020 | Dec 31, 2020 | $1.57M | -16.0% |
| FY2019 | Dec 31, 2019 | $1.87M | -9.1% |
| FY2018 | Dec 31, 2018 | $2.06M | +18.5% |
| FY2017 | Dec 31, 2017 | $1.74M | +11.7% |
| FY2016 | Dec 31, 2016 | $1.55M | +22.1% |
| FY2015 | Dec 31, 2015 | $1.27M | -4.9% |
| FY2014 | Dec 31, 2014 | $1.34M | -20.3% |
| FY2013 | Dec 31, 2013 | $1.68M | +3.2% |
| FY2012 | Dec 31, 2012 | $1.63M | -6.3% |
| FY2011 | Dec 31, 2011 | $1.74M | +7.6% |
| FY2010 | Dec 31, 2010 | $1.61M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $947.00K | -0.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.04M | +2.4% |
| Q4 FY2025 | Dec 31, 2025 | $1.04M | -5.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.08M | +11.5% |
| Q2 FY2025 | Jun 30, 2025 | $955.00K | +10.5% |
| Q1 FY2025 | Mar 31, 2025 | $1.02M | +11.9% |
| Q4 FY2024 | Dec 31, 2024 | $1.09M | +39.0% |
| Q3 FY2024 | Sep 30, 2024 | $970.00K | -8.2% |
| Q2 FY2024 | Jun 30, 2024 | $864.00K | -12.8% |
| Q1 FY2024 | Mar 31, 2024 | $910.00K | -9.3% |
| Q4 FY2023 | Dec 31, 2023 | $785.00K | +8.0% |
| Q3 FY2023 | Sep 30, 2023 | $1.06M | +24.6% |
| Q2 FY2023 | Jun 30, 2023 | $991.00K | +24.3% |
| Q1 FY2023 | Mar 31, 2023 | $1.00M | +50.6% |
| Q4 FY2022 | Dec 31, 2022 | $727.00K | +28.7% |
| Q3 FY2022 | Sep 30, 2022 | $848.00K | +33.5% |
| Q2 FY2022 | Jun 30, 2022 | $797.00K | +48.7% |
| Q1 FY2022 | Mar 31, 2022 | $666.00K | +33.5% |
| Q4 FY2021 | Dec 31, 2021 | $565.00K | +29.3% |
| Q3 FY2021 | Sep 30, 2021 | $635.00K | +56.8% |
| Q2 FY2021 | Jun 30, 2021 | $536.00K | +50.1% |
| Q1 FY2021 | Mar 31, 2021 | $499.00K | +34.1% |
| Q4 FY2020 | Dec 31, 2020 | $437.00K | +4.0% |
| Q3 FY2020 | Sep 30, 2020 | $405.00K | -17.0% |
| Q2 FY2020 | Jun 30, 2020 | $357.00K | -26.4% |
| Q1 FY2020 | Mar 31, 2020 | $372.00K | -22.0% |
| Q4 FY2019 | Dec 31, 2019 | $420.00K | -22.8% |
| Q3 FY2019 | Sep 30, 2019 | $488.00K | +17.3% |
| Q2 FY2019 | Jun 30, 2019 | $485.00K | -9.9% |
| Q1 FY2019 | Mar 31, 2019 | $477.00K | -14.5% |
| Q4 FY2018 | Dec 31, 2018 | $544.00K | +42.4% |
| Q3 FY2018 | Sep 30, 2018 | $416.00K | -15.8% |
| Q2 FY2018 | Jun 30, 2018 | $538.00K | +13.0% |
| Q1 FY2018 | Mar 31, 2018 | $558.00K | +45.3% |
| Q4 FY2017 | Dec 31, 2017 | $382.00K | -22.7% |
| Q3 FY2017 | Sep 30, 2017 | $494.00K | +28.0% |
| Q2 FY2017 | Jun 30, 2017 | $476.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $384.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $494.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $386.00K | – |
See a number that looks wrong?